Fredrik Odin serves as a Board Member at Texray since December 2023 and has been the Investment Director at Impilo since April 2017, where the focus is on investments in Nordic healthcare companies contributing positively to society. Previously, Fredrik held the position of Deputy Board Member and Audit Committee member at Immedica Pharma AB from May 2018 to September 2024, and worked as an Investment Executive at XIO Group and an Investment Banking Analyst at Bank of America Merrill Lynch, specializing in Nordic M&A. Early career experiences include a role as an Investment Banking Summer Analyst at Barclays Investment Bank and as a Diplomatic Assistant at the Embassy of Sweden in Moscow. Fredrik holds an MSc in Finance and Private Equity from The London School of Economics and Political Science and a BSc (Hons) in Economics, Politics and International Studies from the University of Warwick.
This person is not in the org chart
This person is not in any teams
This person is not in any offices